GlassScriptPhysician profile
Richard A Conlen
NPI 1942260781
$1,706.49
in general payments reported to CMS, 2019-2025
20 companies · $371 in 2025
The $371 reported for 2025 was more than what a typical Gynecology provider received nationally (typical 2025 total: $162).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $108 · 2020: $121 · 2021: $373 · 2022: $237 · 2023: $220 · 2024: $277 · 2025: $371.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $769 · Education: $99.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $768.74 |
| Education | $99.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $309.77 | 2023-2025 | Veozah, Myrbetriq |
| Mayne Pharma Commercial LLC | $223.17 | 2021-2024 | |
| Gynesonics, INC. | $185.61 | 2021-2022 | |
| Abbvie INC. | $148.68 | 2019-2025 | |
| Myovant Sciences INC. | $143.36 | 2021 | |
| Baxter Healthcare | $134.66 | 2025 | Perclot |
| Millicent US INC | $117.69 | 2024-2025 | Intrarosa, Femring, Femlyv |
| Therapeuticsmd, INC. | $90.13 | 2019 | |
| Avion Pharmaceuticals | $66.76 | 2021-2023 | Balcoltra |
| Hologic Sales and Service, LLC | $45.80 | 2020-2024 | Aptima, Thinprep 2000 Processor |
| Lupin INC. | $45.51 | 2020 | |
| Scynexis, INC. | $43.29 | 2022 | |
| Virtus Pharmaceuticals LLC | $33.09 | 2021-2022 | |
| Smith+Nephew, INC. | $26.31 | 2023 | Grafix Pl, Stravix |
| Exeltis, USA INC. | $22.92 | 2024 | Slynd |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Coopersurgical, INC. | $20.03 | 2021 | |
| Exact Sciences Corporation | $19.02 | 2025 | The Cologuard Plus Collection Kit |
| Allergan, INC. | $18.27 | 2020 | |
| Amag Pharmaceuticals, INC. | $12.42 | 2020 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$5.00 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Richard Conlen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.